Animal models for cystic fibrosis: a systematic search and mapping review of the literature. Part 2: nongenetic models.

Animal models cystic fibrosis outcome measures search string systematic map

Journal

Laboratory animals
ISSN: 1758-1117
Titre abrégé: Lab Anim
Pays: England
ID NLM: 0112725

Informations de publication

Date de publication:
Aug 2021
Historique:
pubmed: 10 2 2021
medline: 29 10 2021
entrez: 9 2 2021
Statut: ppublish

Résumé

Various animal models are available to study cystic fibrosis (CF). These models may help to enhance our understanding of the pathology and contribute to the development of new treatments. We systematically searched all publications on CF animal models. Because of the large number of models retrieved, we split this mapping review into two parts. Previously, we presented the genetic CF animal models. In this paper we present the nongenetic CF animal models. While genetic animal models may, in theory, be preferable for genetic diseases, the phenotype of a genetic model does not automatically resemble human disease. Depending on the research question, other animal models may thus be more informative.We searched Pubmed and Embase and identified 12,303 unique publications (after duplicate removal). All references were screened for inclusion by two independent reviewers. The genetic animal models for CF (from 636 publications) were previously described. The non-genetic CF models (from 189 publications) are described in this paper, grouped by model type: infection-based, pharmacological, administration of human materials, xenografts and other. As before for the genetic models, an overview of basic model characteristics and outcome measures is provided. This CF animal model overview can be the basis for an objective, evidence-based model choice for specific research questions. Besides, it can help to retrieve relevant background literature on outcome measures of interest.

Identifiants

pubmed: 33557683
doi: 10.1177/0023677221990688
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

307-316

Auteurs

Cathalijn Hc Leenaars (CH)

SYRCLE, Department for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, The Netherlands.
Faculty of Veterinary Medicine, Department of Animals in Science and Society, Utrecht University, The Netherlands.
Institute for Laboratory Animal Science, Hannover Medical School, Germany.

Rob Bm de Vries (RB)

SYRCLE, Department for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, The Netherlands.

Joey Reijmer (J)

SYRCLE, Department for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, The Netherlands.

David Holthaus (D)

SYRCLE, Department for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, The Netherlands.

Damian Visser (D)

SYRCLE, Department for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, The Netherlands.

Anna Heming (A)

SYRCLE, Department for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, The Netherlands.

Janneke Elzinga (J)

SYRCLE, Department for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, The Netherlands.

Rosalie Wm Kempkes (RW)

SYRCLE, Department for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, The Netherlands.

Wouter Beumer (W)

ProQR Therapeutics NV, Leiden, The Netherlands.

Carine Punt (C)

ProQR Therapeutics NV,Leiden, the Netherlands; Present position: BunyaVax BV, Lelystad, The Netherlands.

Franck Lb Meijboom (FL)

Faculty of Veterinary Medicine, Department of Animals in Science and Society, Utrecht University, The Netherlands.

Merel Ritskes-Hoitinga (M)

SYRCLE, Department for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, The Netherlands.
Department of Clinical Medicine, Aarhus University, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH